Sbir phase III proposal no. JW230017 titled, "optimized, field-stable glycopolymer-mimicking polysaccharide to prevent morbidity and mortality in exposure to ionizing radiation or nuclear injury"
Ended Definitive Contract Awarded Last action
- Contract number
- HT942524C0049
- Awardee
-
Synedgen, Inc. UEI HX79BD6YQ521
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $2,297,415
Award facts
- Opportunity
-
- HT942523RJWMR Solicitation number
- Contract value 100% obligated
- $2,297,415.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Claremont, CA 91711, USA
- Research
- SBIR Program Phase III Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $2,297,415 |
About this award
This is a Small Business Innovation Research (SBIR) Phase III contract awarded by the Defense Health Agency (DHA) to Synedgen, Inc., a small business located in Claremont, California. The contract, valued at $2,297,415.00, is for the development of an "optimized, field-stable glycopolymer-mimicking polysaccharide to prevent morbidity and mortality in exposure to ionizing radiation or nuclear injury." This contract builds upon earlier SBIR-funded research and is intended to deliver an advanced medical technology to address complex challenges related to radiation exposure and injury. As an SBIR Phase III contract, this award represents a critical stage in transitioning the technology from research and development to production and commercialization. The contract has a firm-fixed-price pricing structure and a period of performance that extends through September 19, 2026.
Quick answers
Who was awarded contract HT942524C0049?
HT942524C0049 was awarded to Synedgen, Inc. by Defense Health Agency (Department of Defense) on September 20, 2024.
How much is contract HT942524C0049 worth?
The government has obligated $2,297,415 on HT942524C0049.
Was contract HT942524C0049 competed?
The extent of competition for HT942524C0049 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award